BHP Group Half-Year Profit Surges as Copper Overtakes Iron Ore on AI-Driven Demand 
Treasury Wine Estates Profit Falls 46% as China and U.S. Inventory Reset Weighs on Earnings 
Bank of America CEO Brian Moynihan’s 2025 Compensation Rises 17% to $41 Million Amid Strong Profit Growth 
Paramount Skydance Appoints Rene Augustine as SVP of Global Public Policy Amid Warner Bros Takeover Battle 
Macquarie-Led Consortium to Acquire Qube Holdings in A$11.7 Billion Deal 
Federal Court Fines Mobil Oil Australia A$16 Million for Misleading Fuel Claims 
Santos Wins Court Case Over Net Zero and Sustainability Claims 
Anduril Industries Seeks $8 Billion Funding at $60 Billion Valuation 
AstroTurf Expands Footprint at Colorado as Buffaloes Complete Second Installation in 12 Months 
Valero Energy Expands Venezuelan Crude Imports as U.S. Sanctions Ease 
Grok AI Market Share Surges as xAI Faces Scrutiny Over Image Generation Controversy 
Lockheed Martin Secures $101M in U.S. Defense Contracts for AEGIS, F-35, and Missile Systems 
Starboard Value Targets Tripadvisor Board Overhaul Amid Stock Slump 
Bain Capital Secures RBI Approval to Acquire Up to 41.7% Stake in Manappuram Finance 
Goldman Sachs Reportedly Drops Diversity Criteria From Board Candidate Evaluations 
India AI Impact Summit 2026: Global Tech CEOs Join World Leaders in New Delhi 
Luxury Stocks Face Volatility as AI Market Swings and Hedge Fund Bets Rattle LVMH and Kering 
MEDFORD, N.Y., April 26, 2018 -- Chembio Diagnostics, Inc. (Nasdaq:CEMI), a leader in point-of-care diagnostic tests for infectious diseases, announced today that it will release financial results for the first quarter 2018 after the close of trading on Wednesday, May 9, 2018. The Company’s management team will host a corresponding conference call beginning at 4:30 pm ET.
Investors interested in listening to the conference call may do so by dialing 877-407-0778 from the US or 201-689-8565 from outside the US. A live and archived webcast of the event will be available on the “Investors” section of the Company’s website at www.chembio.com. A telephone replay will be available by dialing 877-481-4010 from the US or 919-882-2331 from outside the US using passcode 28132 until 4:30pm ET on Wednesday, May 16, 2018.
Contact:
Lynn Pieper Lewis
Gilmartin Group
Investor Relations
(415) 937-5402
[email protected]
